Skip to main content

Table 2 Current GABHS Resistance Rates

From: Genetic commonality of macrolide-resistant group A beta hemolytic streptococcus pharyngeal strains

  Site A Site B
Macrolide-Susceptible 192/200 (96%) 188/200 (94%)
Macrolide-Intermediate 1/200 (0.5%) 3/200 (1.5%)
Macrolide-Resistant 7/200 (3.5%) 9/200 (4.5%)
Inducible Clindamycin Resistancea 3/7 (42.9%) 3/9 (33.3%)
  1. a Determined by double disk diffusion (D-test)